← Leaderboards
David M Knipe
Harvard Medical School
$35,817,264
Attributed
$35,817,264
Total exposure
25
Grants
18
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $4.2M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$57,576,716 · 27
By mechanism
P01$31,421,990 · 13
R01$14,067,236 · 6
T32$9,961,170 · 1
R56$1,479,519 · 3
R21$253,500 · 1
U54$227,474 · 1
Top collaborators
- Donald M Coen4 shared
Most similar at Harvard Medical School
Same institution · by research overlap
- Karen L Adelman$3,834,499
- Kevin Francis Bryant$102,208
Others in their field
Top investigators on “Viral”
- Lawrence Corey · Fred Hutchinson Cancer Center$466,994,927
- David Heimbrook · Leidos Biomedical Research, Inc.$366,090,791
- Daniel R Kuritzkes · Brigham And Women'S Hospital$267,074,199
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$252,763,614
- Judith S. Currier · University Of California Los Angeles$185,434,785
- Constance Ann Benson · University Of California, San Diego$165,517,633
Research focus
ViralSimplexvirusProteinsVirusGene ExpressionGenesMutantInfectionLatent InfectionCellsResponseChromatinViral GenomeGenetic TranscriptionHeterochromatinSiteVirus ReplicationBaseMaintenanceHerpesvirus 1, HumanNeuronsLytic PhaseMolecularViral Dna
Grant awards (111)
Molecular Basis of Viral Infectivity$461,243
T32 · FY2025 · AI · contact PI
Mechanisms of Infection and Transduction by A New HSV Gene Therapy Vector$253,500
R21 · FY2025 · AI · contact PI
Molecular Basis of Viral Infectivity$591,696
T32 · FY2024 · AI · contact PI
Nuclear Sensing of Herpesviral DNA$587,026
R56 · FY2024 · AI · contact PI
VIral and host mechanisms that tilt the HSV lytic/latent balance$2,129,998
P01 · FY2023 · AI · contact PI
Molecular Basis of Viral Infectivity$480,765
T32 · FY2023 · AI · contact PI
Project 1 - Chromatin and the lytic/latent balance$473,132
P01 · FY2023 · AI · contact PI
VIral and host mechanisms that tilt the HSV lytic/latent balance$2,129,998
P01 · FY2022 · AI
Molecular Basis of Viral Infectivity$484,363
T32 · FY2022 · AI · contact PI
Project 1 - Chromatin and the lytic/latent balance$473,131
P01 · FY2022 · AI · contact PI
VIral and host mechanisms that tilt the HSV lytic/latent balance$2,129,998
P01 · FY2021 · AI
Nuclear Sensing of Herpesviral DNA$483,762
R01 · FY2021 · AI · contact PI
Molecular Basis of Viral Infectivity$482,794
T32 · FY2021 · AI · contact PI
Project 1 - Chromatin and the lytic/latent balance$473,132
P01 · FY2021 · AI · contact PI
VIral and host mechanisms that tilt the HSV lytic/latent balance$2,130,974
P01 · FY2020 · AI
Nuclear Sensing of Herpesviral DNA$522,076
R01 · FY2020 · AI · contact PI
Molecular Basis of Viral Infectivity$480,793
T32 · FY2020 · AI · contact PI
Project 1 - Chromatin and the lytic/latent balance$470,372
P01 · FY2020 · AI · contact PI
VIral and host mechanisms that tilt the HSV lytic/latent balance$2,164,748
P01 · FY2019 · AI
Nuclear Sensing of Herpesviral DNA$522,076
R01 · FY2019 · AI · contact PI
Molecular Basis of Viral Infectivity$487,080
T32 · FY2019 · AI · contact PI
Project 1 - Chromatin and the lytic/latent balance$473,133
P01 · FY2019 · AI · contact PI
Nuclear Sensing of Herpesviral DNA$522,076
R01 · FY2018 · AI · contact PI
Chromatin and the Lytic/Latent Balance$493,157
P01 · FY2017 · AI · contact PI
Nuclear Sensing of Herpesviral DNA$443,487
R01 · FY2017 · AI · contact PI
Nuclear Sensing of Herpesviral DNA$443,487
R01 · FY2016 · AI · contact PI
Chromatin and the Lytic/Latent Balance$411,037
P01 · FY2016 · AI · contact PI
Molecular Basis of Viral Infectivity$447,546
T32 · FY2015 · AI · contact PI
Nuclear Sensing of Herpesviral DNA$443,487
R01 · FY2015 · AI · contact PI
Chromatin and the Lytic/Latent Balance$418,208
P01 · FY2015 · AI · contact PI
Molecular Basis of Viral Infectivity$602,779
T32 · FY2014 · AI · contact PI
Chromatin and the Lytic/Latent Balance$496,279
P01 · FY2014 · AI · contact PI
International Herpes Vaccine Project$496,204
R01 · FY2014 · AI · contact PI
Nuclear Sensing of Herpesviral DNA$443,487
R01 · FY2014 · AI · contact PI
Epigenetic Regulation of HSV Infection of Oral Cells$411,038
R56 · FY2014 · DE · contact PI
Chromatin and Herpes Simplex Virus Latency$464,477
R01 · FY2013 · AI · contact PI
Epigenetic Regulation of HSV Infection of Oral Cells$411,038
R56 · FY2013 · DE · contact PI
International Herpes Vaccine Project$398,325
R01 · FY2013 · AI · contact PI
Genetics of Herpesvirus Transformation$390,399
R01 · FY2013 · AI · contact PI
Chromatin and the Lytic/Latent Balance$192,670
P01 · FY2013 · AI · contact PI
International Herpes Vaccine Project$65,118
R01 · FY2013 · AI · contact PI
Chromatin and Herpes Simplex Virus Latency$493,293
R01 · FY2012 · AI · contact PI
MOLECULAR BASIS OF VIRAL INFECTIVITY$450,853
T32 · FY2012 · AI · contact PI
International Herpes Vaccine Project$422,709
R01 · FY2012 · AI · contact PI
Genetics of Herpesvirus Transformation$415,317
R01 · FY2012 · AI · contact PI
MOLECULAR BASIS OF VIRAL INFECTIVITY$473,347
T32 · FY2011 · AI · contact PI
Genetics of Herpesvirus Transformation$415,317
R01 · FY2011 · AI · contact PI
International Herpes Vaccine Project$352,083
R01 · FY2011 · AI · contact PI
International Herpes Vaccine Project$70,417
R56 · FY2011 · AI · contact PI
Herpesviruses as Vaccine Vectors for AIDS$731,734
P01 · FY2010 · AI · contact PI
MOLECULAR BASIS OF VIRAL INFECTIVITY$471,471
T32 · FY2010 · AI · contact PI
HSV Studies$469,909
P01 · FY2010 · NS · contact PI
Genetics of Herpesvirus Transformation$454,797
R01 · FY2010 · AI · contact PI
Development of HSV Vector as AIDS Vaccines$164,162
P01 · FY2010 · AI · contact PI
Administrative Core$81,245
P01 · FY2010 · AI · contact PI
Herpesviruses as Vaccine Vectors for AIDS$1,762,403
P01 · FY2009 · AI · contact PI
Development of HSV Vectors as AIDS Vaccines$500,001
P01 · FY2009 · AI · contact PI
MOLECULAR BASIS OF VIRAL INFECTIVITY$476,596
T32 · FY2009 · AI · contact PI
HSV Studies$461,709
P01 · FY2009 · NS · contact PI
Genetics of Herpesvirus Transformation$423,646
R01 · FY2009 · AI · contact PI
International Herpes Vaccine Project$394,157
R01 · FY2009 · AI · contact PI
Administrative Core$223,956
P01 · FY2009 · AI · contact PI
Herpesviruses as Vaccine Vectors for AIDS$1,226,620
P01 · FY2008 · AI · contact PI
MOLECULAR BASIS OF VIRAL INFECTIVITY$473,577
T32 · FY2008 · AI · contact PI
HSV Studies$442,252
P01 · FY2008 · NS · contact PI
International Herpes Vaccine Project$394,157
R01 · FY2008 · AI · contact PI
Genetics of Herpesvirus Transformation$354,743
R01 · FY2008 · AI · contact PI
Development of HSV Vectors as AIDS Vaccines$347,910
P01 · FY2008 · AI · contact PI
Microbial Vectors for Antigen Delivery$227,474
U54 · FY2008 · AI · contact PI
Administrative Core$155,856
P01 · FY2008 · AI · contact PI
Herpesviruses as Vaccine Vectors for AIDS$1,213,954
P01 · FY2007 · AI · contact PI
International Herpes Vaccine Project$401,791
R01 · FY2007 · AI · contact PI
Development of HSV Vectors as AIDS Vaccines$395,092
P01 · FY2007 · AI · contact PI
Genetics of Herpesvirus Transformation$361,613
R01 · FY2007 · AI · contact PI
HSV Studies$345,042
P01 · FY2007 · NS · contact PI
Molecular Basis of Viral Infectivity$330,635
T32 · FY2007 · AI · contact PI
Herpesviruses as Vaccine Vectors for AIDS$1,213,797
P01 · FY2006 · AI · contact PI
Molecular Basis of Viral Infectivity$414,939
T32 · FY2006 · AI · contact PI
International Herpes Vaccine Project$413,792
R01 · FY2006 · AI · contact PI
HSV Studies$413,708
P01 · FY2006 · NS · contact PI
Genetics of Herpesvirus Transformation$372,414
R01 · FY2006 · AI · contact PI
Development of HSV Vectors as AIDS Vaccines$342,665
P01 · FY2006 · AI · contact PI
Herpesviruses as Vaccine Vectors for AIDS$1,052,099
P01 · FY2005 · AI
Molecular Basis of Viral Infectivity$462,957
T32 · FY2005 · AI
International Herpes Vaccine Project$423,750
R01 · FY2005 · AI
Genetics of Herpesvirus Transformation$381,375
R01 · FY2005 · AI
Development of HSV Vectors as AIDS Vaccines$276,478
P01 · FY2005 · AI
Administrative Core$152,299
P01 · FY2005 · AI
Molecular Basis of Viral Infectivity$462,752
T32 · FY2004 · AI
Genetics of Herpesvirus Transformation$190,688
R01 · FY2004 · AI
HERPESVIRUSES AS VACCINE VEHICLES FOR AIDS$64,424
P51 · FY2004 · RR
HERPESVIRUSES AS VACCINE VECTORS FOR AIDS$984,549
P01 · FY2003 · AI
Molecular Basis of Viral Infectivity$451,970
T32 · FY2003 · AI
MATURATION OF HERPESVIRAL NUCLEAR PROTEINS$380,218
R01 · FY2003 · AI
HERPES VIRUS RECOMBINANTS AS AIDS VACCINE VECTORS$101,403
P51 · FY2003 · RR
HERPESVIRUSES AS VACCINE VECTORS FOR AIDS$914,023
P01 · FY2002 · AI
MOLECULAR BASIS OF VIRAL INFECTIVITY$365,260
T32 · FY2002 · AI
MATURATION OF HERPESVIRAL NUCLEAR PROTEINS$326,112
R01 · FY2002 · AI
HERPES SIMPLEX VIRUS AS AN AIDS VACCINE VECTOR$0
P01 · FY2002 · AI
Role of host immune response in herpes latency$0
P01 · FY2002 · NS
HERPESVIRUSES AS VACCINE VECTORS FOR AIDS$1,057,488
P01 · FY2001 · AI
MATURATION OF HERPESVIRAL NUCLEAR PROTEINS$359,901
R01 · FY2001 · AI
MOLECULAR BASIS OF VIRAL INFECTIVITY$288,250
T32 · FY2001 · AI
HERPES SIMPLEX VIRUS AS AN AIDS VACCINE VECTOR$0
P01 · FY2001 · AI
Role of host immune response in herpes latency$0
P01 · FY2001 · NS
HERPESVIRUSES AS VACCINE VECTORS FOR AIDS$917,069
P01 · FY2000 · AI
MATURATION OF HERPESVIRAL NUCLEAR PROTEINS$351,267
R01 · FY2000 · AI
GENETICS OF HERPESVIRUS TRANSFORMATION$345,635
R01 · FY2000 · CA
MOLECULAR BASIS OF VIRAL INFECTIVITY$319,504
T32 · FY2000 · AI
HERPES SIMPLEX VIRUS AS AN AIDS VACCINE VECTOR$279,635
P01 · FY2000 · AI
HSV 1 IMMUNE EVASION AND THE HOST IMMUNE RESPONSE$236,368
P01 · FY2000 · AI